Skip to content
TriangleGet started
← Childhood Non-Hodgkin Lymphoma

FOR PATIENTS · SOURCE READING

Treatment of lymphoproliferative disease associated with primary immunodeficiency

Source: Childhood Non-Hodgkin Lymphoma Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: May 9, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Context: Treatment Options for Childhood Non-Hodgkin Lymphoma / Lymphoproliferative Disease Associated With Immunodeficiency in Children

For information about the treatments listed below, see Treatment Option Overview.

Source links and citations

Treatment of lymphoproliferative disease in children and adolescents with weakened immune systems may include:

Source links and citations

chemotherapy with or without targeted therapy (rituximab)

Source links and citations

stem cell transplant with cells from a donor may be used to treat the primary immunodeficiency and to decrease the risk of cancer coming back

Source links and citations

Preserved source evidence · Independent clinical review pending · Not medical advice